Menzies D, Pai M, Comstock G: Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research. Ann Intern Med. 2007, 146: 340-354.
Article
PubMed
Google Scholar
Pai M, Zwerling A, Menzies D: Systematic Review: T-Cell-based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update. Ann Intern Med. 2008, 149: 177-184.
Article
PubMed Central
PubMed
Google Scholar
Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, Taksande B, et al: Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection. 2007, 35: 98-103. 10.1007/s15010-007-6114-z.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W: Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006, 44: 2844-2850. 10.1128/JCM.02411-05.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P: Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res. 2006, 7: 56-10.1186/1465-9921-7-56.
Article
PubMed Central
PubMed
Google Scholar
Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, et al: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet. 2006, 367: 1328-1334. 10.1016/S0140-6736(06)68579-6.
Article
CAS
PubMed
Google Scholar
Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, et al: Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals. Am J Respir Crit Care Med. 2007, 175: 737-742. 10.1164/rccm.200608-1088OC.
Article
PubMed Central
PubMed
Google Scholar
Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G, et al: IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 2005, 7: 1-8. 10.1016/j.micinf.2004.09.004.
Article
CAS
PubMed
Google Scholar
Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P: IP-10/CXCL10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect. 2007, 9: 806-812. 10.1016/j.micinf.2007.02.021.
Article
CAS
PubMed
Google Scholar
Ruhwald M, Petersen J, Kofoed K, Nakaoka H, Cuevas LE, Lawson L, et al: Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE. 2008, 3: e2858-10.1371/journal.pone.0002858.
Article
PubMed Central
PubMed
Google Scholar
Ruhwald M, Bodmer T, Maier C, Jepsen M, Andersen MB, Eugen-Olsen J, et al: Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of TB. Eur Respir J. 2008, 32 (6): 1607-1615. 10.1183/09031936.00055508.
Article
CAS
PubMed
Google Scholar
Proost P, Wuyts A, Van Damme J: Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol. 1996, 59: 67-74.
CAS
PubMed
Google Scholar
Ragno S, Romano M, Howell S, Pappin DJ, Jenner PJ, Colston MJ: Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology. 2001, 104: 99-108. 10.1046/j.1365-2567.2001.01274.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lee JH, Chang JH: Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis. Korean J Intern Med. 2003, 18: 138-145.
Article
PubMed Central
CAS
PubMed
Google Scholar
Daly C, Rollins BJ: Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation. 2003, 10: 247-257.
Article
CAS
PubMed
Google Scholar
Lee JS, Song CH, Lim JH, Lee KS, Kim HJ, Park JK, et al: Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy. Inflamm Res. 2003, 52: 297-304.
CAS
PubMed
Google Scholar
Juffermans NP, Verbon A, van Deventer SJ, van DH, Belisle JT, Ellis ME, et al: Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun. 1999, 67: 4295-4297.
PubMed Central
CAS
PubMed
Google Scholar
Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A, et al: Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol. 2001, 107: 664-670. 10.1067/mai.2001.113524.
Article
CAS
PubMed
Google Scholar
Andersen P, Doherty TM, Pai M, Weldingh K: The prognosis of latent tuberculosis: can disease be predicted?. Trends in Molecular Medicine. 2007, 13: 175-182. 10.1016/j.molmed.2007.03.004.
Article
PubMed
Google Scholar